GlassScriptPhysician profile
Stephen Chiu Yang
NPI 1073976106
$4,353.00
in general payments reported to CMS, 2019-2025
12 companies · $314 in 2025
The $314 reported for 2025 was more than what 87% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,460 · 2023: $207 · 2024: $1,372 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,169 · Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,169.31 |
| Food and Beverage | $723.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,429.41 | 2022-2024 | |
| Medtronic, INC. | $287.97 | 2022-2025 | Cobalt Dr Mri Surescan, Micra, Omniasecure Mri Surescan |
| Biosense Webster, INC. | $148.85 | 2022-2025 | Carto 3 |
| Merck Sharp & Dohme LLC | $125.68 | 2023-2025 | Bridion, Keytruda |
| Astrazeneca Pharmaceuticals LP | $123.68 | 2022 | |
| Abiomed | $65.75 | 2024 | Impella |
| Abbott Laboratories | $44.54 | 2025 | Assurity |
| Edwards Lifesciences Corporation | $39.98 | 2023 | Sapien 3 Ultra Resilia |
| Eagle Pharmaceuticals, INC. | $22.59 | 2023 | |
| Endo Pharmaceuticals INC. | $22.35 | 2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $22.30 | 2025 | Gemtesa |
| Boston Scientific Corporation | $19.90 | 2025 | General - Ep |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.